These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53 AND Diagnosis
436 results:

  • 1. LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53-driven tumour progression through miR-5683/FGF2.
    Liu N; Jiang X; Zhang G; Long S; Li J; Jiang M; Jia G; Sun R; Zhang L; Zhang Y
    Clin Transl Med; 2024 Jul; 14(7):e1777. PubMed ID: 39039912
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation].
    Zan LK; Shen LL; Zhang X; Gao N; Tian BG; Geng XX; Peng X; Li JW; Bu P; Zhao GH
    Zhonghua Zhong Liu Za Zhi; 2024 Jul; 46(7):686-695. PubMed ID: 39034804
    [No Abstract]    [Full Text] [Related]  

  • 3. Unlocking the potential of flavonoids: Natural solutions in the fight against colon cancer.
    Hasibuan PAZ; Simanjuntak Y; Hey-Hawkins E; Lubis MF; Rohani AS; Park MN; Kim B; Syahputra RA
    Biomed Pharmacother; 2024 Jul; 176():116827. PubMed ID: 38850646
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification and clinicopathological analysis of potential p73-regulated biomarkers in colorectal cancer via integrative bioinformatics.
    Bareja C; Dwivedi K; Uboveja A; Mathur A; Kumar N; Saluja D
    Sci Rep; 2024 Apr; 14(1):9894. PubMed ID: 38688978
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Exploring the Key Signaling Pathways and ncRNAs in colorectal cancer.
    Lee YJ; Kim WR; Park EG; Lee DH; Kim JM; Shin HJ; Jeong HS; Roh HY; Kim HS
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674135
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Helminth-derived molecules improve 5-fluorouracil treatment on experimental colon tumorigenesis.
    Mendoza-Rodríguez MG; Medina-Reyes D; Sánchez-Barrera CA; Fernández-Muñoz KV; García-Castillo V; Ledesma-Torres JL; González-González MI; Reyes JL; Pérez-Plascencia C; Rodríguez-Sosa M; Vaca-Paniagua F; Meraz MA; Terrazas LI
    Biomed Pharmacother; 2024 Jun; 175():116628. PubMed ID: 38663106
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The Development of Serrated Epithelial Change in Ulcerative Colitis is not Significantly Associated With Increased Histologic Inflammation.
    Bahceci D; Wang D; Lauwers GY; Choi WT
    Am J Surg Pathol; 2024 Jun; 48(6):719-725. PubMed ID: 38584461
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Characterization of cell cycle, inflammation, and oxidative stress signaling role in non-communicable diseases: Insights into genetic variants, microRNAs and pathways.
    D'Antona S; Porro D; Gallivanone F; Bertoli G
    Comput Biol Med; 2024 May; 174():108346. PubMed ID: 38581999
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
    Yu K; Fang X
    Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer Risks Associated With
    Fortuno C; Feng BJ; Carroll C; Innella G; Kohlmann W; Lázaro C; Brunet J; Feliubadaló L; Iglesias S; Menéndez M; Teulé A; Ballinger ML; Thomas DM; Campbell A; Field M; Harris M; Kirk J; Pachter N; Poplawski N; Susman R; Tucker K; Wallis M; Williams R; Cops E; Goldgar D; ; James PA; Spurdle AB
    JCO Precis Oncol; 2024 Feb; 8():e2300453. PubMed ID: 38412388
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor location matters, next generation sequencing mutation profiling of left-sided, rectal, and right-sided colorectal tumors in 552 patients.
    Ciepiela I; Szczepaniak M; Ciepiela P; Hińcza-Nowak K; Kopczyński J; Macek P; Kubicka K; Chrapek M; Tyka M; Góźdź S; Kowalik A
    Sci Rep; 2024 Feb; 14(1):4619. PubMed ID: 38409377
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multi-omic profiling reveals associations between the gut microbiome, host genome and transcriptome in patients with colorectal cancer.
    Zou S; Yang C; Zhang J; Zhong D; Meng M; Zhang L; Chen H; Fang L
    J Transl Med; 2024 Feb; 22(1):175. PubMed ID: 38369542
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system.
    Tang J; Lam GT; Brooks RD; Miles M; Useckaite Z; Johnson IR; Ung BS; Martini C; Karageorgos L; Hickey SM; Selemidis S; Hopkins AM; Rowland A; Vather R; O'Leary JJ; Brooks DA; Caruso MC; Logan JM
    Cancer Lett; 2024 Mar; 585():216639. PubMed ID: 38290660
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Interplay of LncRNA TUG1 and TGF-β/p53 Expression in colorectal cancer.
    Ibrahim BA; Gobran MA; Metwalli AM; Abd Elhady WA; Tolba AM; Omar WE
    Asian Pac J Cancer Prev; 2023 Nov; 24(11):3957-3968. PubMed ID: 38019256
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Combinational antibody detection approach increases the clinical validity of colorectal cancer screening.
    Kobayashi S; Hiwasa T; Kitamura K; Kano M; Hoshino T; Hirano S; Hashimoto M; Seimiya M; Shimada H; Nomura F; Matsubara H; Matsushita K
    J Clin Lab Anal; 2023 Nov; 37(21-22):e24978. PubMed ID: 37964630
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Sequencing paired tumor DNA and white blood cells improves circulating tumor DNA tracking and detects pathogenic germline variants in localized colon cancer.
    Gimeno-Valiente F; Martín-Arana J; Tébar-Martínez R; Gambardella V; Martínez-Ciarpaglini C; García-Micó B; Martínez-Castedo B; Palomar B; García-Bartolomé M; Seguí V; Huerta M; Moro-Valdezate D; Pla-Martí V; Pérez-Santiago L; Roselló S; Roda D; Cervantes A; Tarazona N
    ESMO Open; 2023 Dec; 8(6):102051. PubMed ID: 37951129
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. CLDN6 inhibits colorectal cancer proliferation dependent on restraining p53 ubiquitination via ZO-1/PTEN axis.
    Dong Y; Xu W; Qi D; Qu H; Jin Q; Sun M; Wang X; Quan C
    Cell Signal; 2023 Dec; 112():110930. PubMed ID: 37852424
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
    Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
    Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
    [No Abstract]    [Full Text] [Related]  

  • 19. Racial disparities in colorectal cancer clinicopathological and molecular tumor characteristics: a systematic review.
    Lawler T; Parlato L; Warren Andersen S
    Cancer Causes Control; 2024 Feb; 35(2):223-239. PubMed ID: 37688643
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Impacts of some clinicopathodemography and colorectal tissues key cell cycle and mucin stabilizing molecules on the metastasis trend in colorectal cancer patients.
    Ghorbani Ranjbary A; Mehrzad J; Rahbar N; Dehghani H
    Mol Biol Rep; 2023 Oct; 50(10):8589-8601. PubMed ID: 37644368
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 22.